- ... cancer include the following: Anthracyclines. - Doxorubicin. - Epirubicin. - Liposomal ... - Ixabepilone.[ 78 ] Combination regimens that have shown activity in metastatic breast cancer ...
- ... year follow-up Comparison 8. Doxorubicin/epirubicin + docetaxel/paclitaxel + CMF versus doxorubicin/epirubicin (± cyclophosphamide) + CMF Figure 119 Disease-free survival at 3. ...
- ... window Standard treatment Etoposide + cisplatin Etoposide + carboplatin Other regimens Cisplatin + irinotecan Ifosfamide + cisplatin + etoposide Cyclophosphamide + doxorubicin + etoposide Cyclophosphamide + doxorubicin + etoposide + vincristine Cyclophosphamide + etoposide + vincristine ...
- ... Level of evidence: IV ] Capecitabine, cisplatin, cytosine arabinoside, cyclophosphamide, daunorubicin, docetaxel, doxorubicin, 5-fluorouracil, interferon, irinotecan, leucovorin, methotrexate, oxaliplatin, paclitaxel, topotecan, lapatinib, pertuzumab Radiation therapy (Refer to the ...
- ... among patients that had received NAC. The chemotherapy regimens evaluated in the AC trials were CMV, cisplatin/gemcitabine, cisplatin/methotrexate, and cisplatin/doxorubicin/cyclophosphamide. Table 6 Characteristics of studies on adjuvant and ...
- ... area (BSA) with or without additional agents, or doxorubicin 60 mg/m 2 of BSA with ... regimen included an NK-1 antagonist (fosaprepitant or aprepitant), ...
- ... e., cyclophosphamide and vincristine) cycles. Examples of other regimens that have been ... hydroxyurea, and vincristine. CHAMOMA: Methotrexate, folinic acid, ...
- ... The studies investigated a variety of combination chemotherapy regimens ... taxanes (paclitaxel and docetaxel) and from 2003 onwards trials investigated ...
- ... 9-tetrahydrocannabinol as an antiemetic in patients receiving adriamycin and cytoxan chemotherapy. Cancer 47 (7): 1746-51, 1981. [ PubMed : ...
- ... followed by three cycles of adjuvant chemotherapy (cisplatin, doxorubicin and cyclophosphamide; PAC) and then seven cycles of intermittent chemotherapy ...
11 results